000129810 001__ 129810
000129810 005__ 20240319081013.0
000129810 0247_ $$2doi$$a10.1080/13625187.2022.2026326
000129810 0248_ $$2sideral$$a130288
000129810 037__ $$aART-2022-130288
000129810 041__ $$aeng
000129810 100__ $$0(orcid)0000-0003-0045-7871$$aGómez-Torres, Piedad$$uUniversidad de Zaragoza
000129810 245__ $$aAssessing Spaniard men’s willingness and determinants to use a male contraceptive pill
000129810 260__ $$c2022
000129810 5060_ $$aAccess copy available to the general public$$fUnrestricted
000129810 5203_ $$aObjective
As the clinical trials to develop male contraceptive pills are underway, understanding men’s attitudes towards this contraceptive method is transcendental. This research was conducted to identify the degree of willingness and the determinants to use male contraceptive pill among Spaniard men.
Methods
A sample of 402 Spaniards men was presented with 36 scenarios comprising four within-subject factors (cost of pills, pill efficacy, side effects and context). In each scenario, a man is asked by his partner to use the contraceptive pill. Participants indicated their own willingness to use the pill in each circumstance.
Results
Cluster analysis revealed that participants took one of seven different positions regarding their willingness to use a contraceptive pill: never agree (10%); mainly depends on pill efficacy (6%); mainly depends on side effects (10%); depends on side effects and efficacy (12%); depends on context and side effects (12%); quite always (25%); always agree (25%). Participants’ willingness to use contraceptive pills was more pronounced in the case of mild side effects and higher pill efficacy.
Conclusion
Fifty percent of participants would use the male pill regardless of the circumstances. Access to this contraceptive method, when available, can contribute to greater equity in reproductive rights of the population.
000129810 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/
000129810 590__ $$a1.7$$b2022
000129810 591__ $$aPUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH$$b168 / 207 = 0.812$$c2022$$dQ4$$eT3
000129810 591__ $$aOBSTETRICS & GYNECOLOGY$$b71 / 85 = 0.835$$c2022$$dQ4$$eT3
000129810 592__ $$a0.621$$b2022
000129810 593__ $$aMedicine (miscellaneous)$$c2022$$dQ2
000129810 593__ $$aReproductive Medicine$$c2022$$dQ2
000129810 593__ $$aPharmacology (medical)$$c2022$$dQ2
000129810 593__ $$aObstetrics and Gynecology$$c2022$$dQ2
000129810 594__ $$a3.0$$b2022
000129810 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/acceptedVersion
000129810 700__ $$aMartínez-Pérez, Guillermo Z.
000129810 700__ $$aGómez-Barrera, Manuel
000129810 700__ $$aMullet, Etienne
000129810 700__ $$aVera Cruz, Germano
000129810 7102_ $$11006$$2255$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Enfermería
000129810 773__ $$g27, 2 (2022), 107-114$$pEur. j. contracpt. reprod. health care$$tEUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE$$x1362-5187
000129810 8564_ $$s346269$$uhttps://zaguan.unizar.es/record/129810/files/texto_completo.pdf$$yPostprint
000129810 8564_ $$s727517$$uhttps://zaguan.unizar.es/record/129810/files/texto_completo.jpg?subformat=icon$$xicon$$yPostprint
000129810 909CO $$ooai:zaguan.unizar.es:129810$$particulos$$pdriver
000129810 951__ $$a2024-03-18-15:19:27
000129810 980__ $$aARTICLE